Nautilus Biotechnology, Inc.

NASDAQ:NAUT

0.6886 (USD) • At close April 30, 2025
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024202320222021202020192018
Operating Activities:
Net Income -70.78-63.675-57.924-50.315-15.619-9.618626.6
Depreciation & Amortization 6.3535.7053.4162.8422.3460.5480
Deferred Income Tax 0000000
Stock Based Compensation 12.70112.13710.387.9340.3690.110
Change In Working Capital -5.459-3.219-0.788-0.022-1.387-0.5451.327
Accounts Receivables 0000000
Inventory 0000000
Accounts Payables -0.5780.393-0.5611.2610.12300
Other Working Capital -4.881-3.612-0.227-1.283-1.51-0.5451.327
Other Non Cash Items -1.96-2.659-0.890.320.295-0.157-866.225
Operating Cash Flow -59.145-51.711-45.806-39.241-13.996-9.662-238.298
Investing Activities:
Investments In Property Plant And Equipment -2.122-2.442-2.324-2.269-0.921-0.9260
Acquisitions Net 00000.02400
Purchases Of Investments -86.278-112.892-186.591-221.795-68.35900
Sales Maturities Of Investments 071.599163.17585.144.00100
Other Investing Activites 154.65000-0.0244.9761.198
Investing Cash Flow 66.25-43.735-25.74-138.964-25.2794.051.198
Financing Activities:
Debt Repayment 0000000
Common Stock Issued 00.3680.562-7.96275.89900
Common Stock Repurchased 0.5240.2640.23200-0.874-1.198
Dividends Paid 0000000
Other Financing Activities 1.1440.3680.562327.44775.8990.036145,186.604
Financing Cash Flow 1.1440.3680.562327.44775.8990.036145,186.604
Other Information:
Effect Of Forex Changes On Cash 000000-144,948.306
Net Change In Cash 8.249-95.078-70.984149.24236.6240.5951.198
Cash At End Of Period 28.64820.399115.477186.46137.2190.5951.198